Evaluating respiratory functions and exercise capacity in children with neuromuscular diseases
Official title: Evaluation of Respiratory Functions, Thoracoabdominal Movements, and Exercise Capacity in Neuromuscular Diseases
Run by Lokman Hekim University · NCT06756633 · Data updated 2026-11-12
This study is trying to see how well children with Duchenne Muscular Dystrophy and Spinal Muscular Atrophy can breathe and exercise compared to healthy kids.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 5 Years to 15 Years |
| Sex | All |
| Enrollment | 42 (estimated) |
| Sponsor | Lokman Hekim University Government |
| Locations | 1 site (Ankara, Çankaya) |
| Status | Recruiting |
| Started | April 1, 2024 |
| Main results expected | December 1, 2025 |
| Study ends | December 28, 2025 |
| Registry record updated | January 3, 2025 |
| Trial ID | NCT06756633 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include children aged 5 and older diagnosed with Duchenne Muscular Dystrophy or Spinal Muscular Atrophy who can breathe independently.
✕Probably not a fit
Patients with cognitive impairments affecting assessment results, a history of pulmonary surgery, or advanced heart failure may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess respiratory functions, thoracoabdominal movements, and exercise capacity in children diagnosed with Duchenne Muscular Dystrophy (DMD) and Spinal Muscular Atrophy (SMA) compared to healthy controls. Conducted at Lokman Hekim University, the study will include 42 children divided into three groups, each undergoing various tests including spirometry, structured light plethysmography, and functional assessments like the six-minute walk test. The goal is to gather comprehensive data on respiratory and muscular parameters over a 20-month period.
Why it matters
Potential benefit: If successful, this study could enhance understanding of respiratory impairments in children with neuromuscular diseases, leading to improved management strategies.
How similar studies have gone: While similar studies have explored respiratory function in neuromuscular diseases, this specific approach using structured light plethysmography is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
1. Duchenne Muscular Dystrophy (DMD) -Inclusion Criteria: Clinically diagnosed with Duchenne Muscular Dystrophy. Age above 5 years. Able to breathe independently. Willing to participate in the study. -Exclusion Criteria: Presence of cognitive problems that affect the assessment results. History of pulmonary surgery. Advanced heart failure. 2. Spinal Muscular Atrophy (SMA) -Inclusion Criteria: Clinically diagnosed with Spinal Muscular Atrophy. Age above 5 years. Able to breathe independently. Willing to participate in the study. -Exclusion Criteria: Presence of cognitive problems that affect the assessment results. History of pulmonary surgery. Advanced heart failure. 3. Healthy Controls * Inclusion Criteria: No diagnosis of neuromuscular diseases. Age above 5 years. Able to breathe independently. Willing to participate in the study. -Exclusion Criteria: Presence of cognitive problems that affect the assessment results. History of pulmonary surgery. Advanced heart failure.
Where it's running
-
Lokman Hekim University
Ankara, Çankaya, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Bilge Taşkın Gürel, PhD(c)
- Email: taskinbilge@gmail.com
- Phone: +905348172800
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pregnancy-time treatment of fetal SMA: a registry of mother-child outcomes
This registry collects information on pregnancies where a fetus diagnosed with spinal muscular atrophy was treated with a disease‑modifying therapy in the womb to see how the pregnancy and baby fare after birth.
-
Intrathecal Zolgensma in spinal muscular atrophy patients in Japan
This study tests the safety and real‑world effectiveness of intrathecal onasemnogene abeparvovec in SMA patients in Japan.
-
VM100: a nutritional supplement to see if it improves quality of life for boys with Duchenne
This Phase 2 study tests VM100, a nutritional drink, in boys aged 8 and up with Duchenne muscular dystrophy to see if it can improve quality of life and reduce fatigue.
-
Bedside Spirometry to see if tidal volume matches ideal body weight in non-intubated ARDS
This pilot study tests whether tidal volume measured at bedside with high-flow oxygen and after NIV settings can help classify ARDS patients who are not intubated.
-
Early breathing therapy just one hour after CABG extubation
This trial tests whether starting respiratory physiotherapy one hour after extubation improves recovery for adults after elective CABG compared with starting on the first postoperative day.
-
Humidification methods in trauma ICU patients on mechanical ventilation
This study tests whether active heated humidifiers or passive heat-and-moisture exchangers work better in trauma ICU patients who need long-term mechanical ventilation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.